Artificial Cerebrospinal Fluid Market

Global Artificial Cerebrospinal Fluid Market Size, Share & Trends Analysis Report by Type (SGS, USP, and HLPC), By Application (Human and Animals), and Forecast (2021-2027)

Published: Oct 2021 | Report Code: OMR2024335 | Category : Pharmaceuticals | Delivery Format: /

The global artificial cerebrospinal fluid market is expected to grow at a significant CAGR during the forecast period. Artificial cerebrospinal fluid (ACSF) is a buffer solution that is used in experiments to provide oxygen, maintain osmolarity, and buffer pH at biological values to brain slices, isolated brains, or exposed brain regions. ACSF is used as a physiological perfusate during endoneuro surgery and is also used for normal neurosurgical procedures to inhibit host responses within the cerebrospinal fluid pathway. 

Artificial cerebrospinal fluid is frequently used in scientific research to preserve pH balance and tissue oxygen transport, such as rat brain microdialysis studies, and hippocampus tissue slice culture. Nearly 700,000 elderly Americans are estimated to have normal pressure hydrocephalus, according to the Hydrocephalus Association. Furthermore, it is estimated that one to two kids in every 1,000 is born with this disease. This rising prevalence of these conditions is resulting in an increasing demand for artificial cerebrospinal fluid.

Artificial cerebrospinal fluid has the same ion concentration, pH value, and crystal osmotic pressure as human cerebrospinal fluid, preventing many of the adverse effects of regular saline infusion. When cerebrospinal fluid is lost, it can be used as a supplement or as an irrigating solution or as lavage fluid. ACSF may preserve intermediate neurons during brain slice perfusion and is commonly used as a replacement for cerebrospinal fluid. There is increasing use of artificial cerebrospinal fluid in hospitals, clinics, and physicians, as well as other sectors, which in turn, is propelling the market growth.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment covered 

o By Type

o By Application

  • Region covered

o North America

o Europe

o Asia-pacific

o Rest of world

  • Competitive Landscape- Ying Chuang, Funakoshi, Tocris Bioscience, among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Artificial Cerebrospinal Fluid Market Segmentation

  • By Type

o SGS

o USP

o HLPC

  • By Application

o Human

o Animals 

Global Artificial Cerebrospinal Fluid Market Segmentation by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

REQUEST FOR TABLE OF CONTENT